Insmed Incorporated (INSM) Earnings History
Net Loss27 years of earnings data (1999–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Insmed Incorporated (INSM) Earnings Overview
As of June 22, 2026, Insmed Incorporated (INSM) reported trailing twelve-month net income of -$1.18B, reflecting -15.1% year-over-year growth. The company earned $-5.49 per diluted share over the past four quarters, with a net profit margin of -210.5%.
Looking at the long-term picture, INSM's historical earnings data spans multiple years. The company achieved its highest annual net income of $118M in fiscal 2009.
Insmed Incorporated is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RARE (-$609M net income, -85.4% margin), ALNY ($577M net income, 8.4% margin), BMRN ($269M net income, 10.8% margin), INSM has room to improve margins relative to the peer group. Compare INSM vs RARE →
INSM Earnings vs Peers
Earnings metrics vs comparable public companies
INSM Historical Earnings Data (1999–2025)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$1.28B | -39.7% | -$1.18B | $-6.41 | -210.5% | -194.0% |
| 2024 | -$914M | -21.9% | -$878M | $-5.57 | -251.2% | -241.5% |
| 2023 | -$750M | -55.7% | -$710M | $-5.34 | -245.6% | -232.5% |
| 2022 | -$482M | -10.8% | -$457M | $-3.91 | -196.3% | -186.4% |
| 2021 | -$435M | -47.8% | -$375M | $-3.88 | -230.6% | -199.0% |
| 2020 | -$294M | -15.6% | -$265M | $-3.01 | -178.9% | -161.3% |
| 2019 | -$254M | +21.6% | -$235M | $-3.01 | -186.4% | -172.4% |
| 2018 | -$324M | -68.3% | -$307M | $-4.22 | -3297.2% | -3124.9% |
| 2017 | -$193M | -9.3% | -$189M | $-2.89 | - | - |
| 2016 | -$176M | -49.2% | -$173M | $-2.85 | - | - |
| 2015 | -$118M | -49.3% | -$117M | $-2.02 | - | - |
| 2014 | -$79M | -41.2% | -$87M | $-1.84 | -688.3% | -759.7% |
| 2013 | -$56M | -35.5% | -$55M | $-1.60 | -487.6% | -478.4% |
| 2012 | -$41M | +30.7% | -$42M | $-1.56 | - | - |
| 2011 | -$60M | -827.3% | -$62M | $-2.56 | -1350.8% | -1397.3% |
| 2010 | -$6M | -105.4% | -$8M | $-0.49 | -93.0% | -116.9% |
| 2009 | $118M | +855.4% | -$9M | $9.30 | 1140.9% | -83.6% |
| 2008 | -$16M | +21.5% | -$14M | $-1.28 | -133.9% | -123.2% |
| 2007 | -$20M | +64.4% | -$20M | $-1.74 | -265.1% | -271.5% |
| 2006 | -$56M | -37.2% | -$54M | $-5.89 | -5664.9% | -5486.7% |
| 2005 | -$41M | -50.5% | -$27M | $-8.40 | -31243.5% | -20942.0% |
| 2004 | -$27M | -164.2% | -$27M | $-6.95 | -19856.2% | -20018.2% |
| 2003 | -$10M | +71.7% | -$11M | $-2.89 | -6865.3% | -7057.3% |
| 2002 | -$36M | +2.0% | -$37M | $-11.01 | -1862.8% | -1893.8% |
| 2001 | -$37M | +53.5% | -$40M | $-11.31 | -12557.1% | -13576.4% |
| 2000 | -$80M | -924.8% | -$82M | $-43.60 | -133103.3% | -135891.7% |
| 1999 | -$8M | - | -$8M | $-24.70 | -779268.4% | -813000.0% |
Download Data
Export INSM earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into INSM consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
27+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
INSM — Frequently Asked Questions
Quick answers to the most common questions about buying INSM stock.
What is INSM earnings per share (EPS)?
INSM trailing twelve-month (TTM) diluted EPS is $-5.49, reflecting -15.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1999 to 2025 is available in the table on this page.
What is Insmed Incorporated's net income?
Insmed Incorporated (INSM) trailing twelve-month net income is $-1.2B as of 2025. Earnings declined -15.1% year-over-year.
Is INSM profitable?
INSM is not currently profitable on a TTM basis, reporting a net loss of $-1.2B. Net margin is -210.5%. Investors should monitor for a return to profitability.
What is INSM's earnings growth rate?
INSM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1999 to 2025.
What are INSM's profit margins?
Insmed Incorporated net profit margin is -210.5%, operating margin is -194.0%, and gross margin is +79.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -249.3%.
Is INSM growing earnings?
INSM earnings are declining — EPS fell -15.1% year-over-year. TTM net income dropped to $-1.2B. This contrasts with the 5-year CAGR of N/A.
What was INSM's best earnings year?
Insmed Incorporated's highest annual net income on record is $118M, achieved in fiscal year 2009. Earnings history on this page spans 1999 to 2025 and includes all annual and quarterly figures.
What were INSM's earnings last quarter?
INSM's most recent reported quarter was Q1 2026. Net income was $-164M with diluted EPS of $-0.76. For a full breakdown of all quarters, see the quarterly earnings table on this page.